What The $15 Billion Menopause Market Doesn't Count
Key takeaways
- Forbes Women What The $15 Billion Menopause Market Doesn't Count By Geri Stengel,
- Forbes contributors publish independent expert analyses and insights.
- Source: PwC, "From Margin To Mainstream: The Future Of Women's Health," March 2026.
Forbes Women What The $15 Billion Menopause Market Doesn't Count By Geri Stengel,
Forbes contributors publish independent expert analyses and insights. Geri Stengel writes about the success factors of women entrepreneurs. Follow Author Jun 29, 2026, 07:13am EDT--:-- / --:--This voice experience is generated by AI. Learn more.This voice experience is generated by AI. Learn more.Summary Pw C's estimated $10-15 billion menopause market, projected to reach $15-25 billion by 2030, significantly understates its true potential. This benchmark deliberately excludes major downstream health consequences like osteoporosis, cardiovascular disease, and cognitive decline, making it a "floor, not a ceiling." Experts argue the real barrier to care isn't reimbursement, as most hormone therapy is covered, but a critical lack of physician training; fewer than 30% of residents and a third of OB/GYNs receive menopause education. This gap fuels the rise of specialized platforms and diverse care models. With growing philanthropic and private investment, including 25% of US employers now offering menopause benefits, the market's full, unmeasured scope presents a tremendous, untapped opportunity.
Source: PwC, "From Margin To Mainstream: The Future Of Women's Health," March 2026. Adapted.PwC Deals Strategy practice that advises companies on mergers, acquisitions, divestitures, and private equity transactions."PwC put a number on the menopause market: $10 billion to $15 billion today, growing to $15 billion to $25 billion by 2030. That figure has become the benchmark that investors, founders, and employers reach for when sizing the opportunity. But there’s a problem with it.